scholarly journals Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results

2017 ◽  
Vol 43 (3) ◽  
pp. 503-512 ◽  
Author(s):  
Eriene A Youssef ◽  
◽  
Elizabeth Berry-Kravis ◽  
Christian Czech ◽  
Randi J Hagerman ◽  
...  
Keyword(s):  
Fragile X Syndrome ◽  
Fragile X ◽  
Controlled Trial ◽  
Phase 2 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Adolescents And Adults

scholarly journals A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome

2016 ◽  
Vol 37 (8) ◽  
pp. 619-628 ◽  
Author(s):  
Laura Greiss Hess ◽  
Sarah E. Fitzpatrick ◽  
Danh V. Nguyen ◽  
Yanjun Chen ◽  
Kimberly N. Gaul ◽  
...  
Keyword(s):  
Young Children ◽  
Fragile X Syndrome ◽  
Low Dose ◽  
Fragile X ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals A Randomized Double-Blind, Placebo-Controlled Trial of Minocycline in Children and Adolescents with Fragile X Syndrome

2013 ◽  
Vol 34 (3) ◽  
pp. 147-155 ◽  
Author(s):  
Mary Jacena S. Leigh ◽  
Danh V. Nguyen ◽  
Yi Mu ◽  
Tri I. Winarni ◽  
Andrea Schneider ◽  
...  
Keyword(s):  
Children And Adolescents ◽  
Fragile X Syndrome ◽  
Fragile X ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: A phase 2, randomised, double-blind, placebo controlled trial

Maturitas ◽  
2017 ◽  
Vol 100 ◽  
pp. 142-143
Author(s):  
Julia Prague ◽  
Rachel Roberts ◽  
Alexander Comninos ◽  
Sophie Clarke ◽  
Channa Jayasena ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Hot Flushes ◽  
Phase 2 ◽  
Double Blind ◽  
Receptor Antagonism ◽  
Double Blind Placebo ◽  
Novel Treatment ◽  
Neurokinin 3 Receptor
Sign in / Sign up

Export Citation Format

Share Document